Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Assessment of Minimal Residual Disease By Next-Generation Sequencing and Fluorodeoxyglucose-Positron Emission Tomography in Patients with Relapsed/Refractory Multiple Myeloma Treated with Venetoclax in Combination with Carfilzomib and Dexamethasone

Luciano J. Costa, MD PhD, Nicholas Burwick, MD, Andrzej Jakubowiak, MD PhD, Jonathan L. Kaufman, MD, Fernando Cabanillas, MD, Monique Dail, PhD, Sudeep Karve, Abdullah A. Masud, PhD, Xiaoqing Yang, PhD, Orlando F. Bueno, Sarah Mudd, PhD, Jeremy A. Ross, Faith E. Davies

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-134737

Published: 2020

Journal Articles

Impact of Neurocognitive Dysfunction in a Veteran Population Undergoing First Outpatient Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Shakira J. Grant, MBBS, Lindsay M. Hannan, MD MSPH, Jessica L. Brand, PhD, Robert E. Richard, MD PhD, Daniel Y. Wu, MD, Solomon A. Graf, MD, Jonathan Grim, MD PhD, Nicholas Burwick, MD, Thomas R. Chauncey, MD PhD

Blood (2019) 134 (Supplement_1): 5883.

https://doi.org/10.1182/blood-2019-122580

Published: 2019

Journal Articles

Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Luciano J Costa, MD PhD, Edward A. Stadtmauer, MD FACP, Gareth Morgan, MD, Gregory Monohan, MD, Tibor Kovacsovics, MD, Nicholas Burwick, MD, Andrzej Jakubowiak, MD PhD, Jonathan L Kaufman, MD, Mehrdad Mobasher, MD MPH, Kevin J. Freise, PhD, Jeremy A. Ross, PhD, John Pesko, PhD, Wijith Munasinghe, PhD, Saketh Gudipati, MD, Sarah Mudd, PhD, Orlando Bueno, MD PhD, Shaji K. Kumar, MD

Blood (2018) 132 (Supplement 1): 303.

https://doi.org/10.1182/blood-2018-99-117026

Published: 2018

Journal Articles

Association of Monoclonal Gammopathy with Progression to End-Stage Renal Disease Among a National Cohort of US Veterans

Nicholas Burwick, MD, Scott V Adams, Jeffrey A Todd-Stenberg, Nilka R Burrows, Meda E Pavkov, Ann M O'Hare

Blood (2017) 130 (Supplement 1): 2143.

https://doi.org/10.1182/blood.V130.Suppl_1.2143.2143

Published: 2017

Journal Articles

Monoclonal Gammopathies: Electronic Subspecialty Consultation

Nicholas Burwick, MD, Jacob Stein, David A Garcia, MD, Virginia C. Broudy, MD, Robert E. Richard, MD PhD

Blood (2017) 130 (Supplement 1): 673.

https://doi.org/10.1182/blood.V130.Suppl_1.673.673

Published: 2017

Journal Articles

Placental Growth Factor (PlGF) Enhances TLR/MK2 Dependent TNF Gene Transcription and Dissociates miRNAs Targeting TNF Regulatory Transcripts from the Polysome

Laura F. Newell, MD, Nicholas Burwick, MD, Christina A Harrington, PhD, Kristina Vartanian, Julja Burchard, Shernan G. Holtan, MD, Akiko Shimamura, MD PhD, Grover C. Bagby, MD

Blood (2016) 128 (22): 408.

https://doi.org/10.1182/blood.V128.22.408.408

Published: 2016

Journal Articles

Response: Maternal and cord C5a in response to eculizumab

Richard M. Burwick, Nicholas Burwick, Bruce B. Feinberg

Blood (2015) 126 (2): 279–280.

https://doi.org/10.1182/blood-2015-06-642553

Published: 2015

Journal Articles

CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma

Abdel Kareem Azab, Ilyas Sahin, Feda Azab, Michele Moschetta, Yuji Mishima, Nicholas Burwick, Johann Zimmermann, Barbara Romagnoli, Kalpana Patel, Eric Chevalier, Aldo M. Roccaro, Irene M. Ghobrial

Blood (2014) 124 (12): 1905–1914.

https://doi.org/10.1182/blood-2014-02-558742

Published: 2014

Journal Articles

Translational Profiling Reveals The eIF2 Kinase Pathway As a Mediator Of Dexamethasone Induced Apoptosis In Multiple Myeloma

Nicholas Burwick, MD, Jeffrey J Delrow, Ph.D, Akiko Shimamura, MD, PhD

Blood (2013) 122 (21): 3104.

https://doi.org/10.1182/blood.V122.21.3104.3104

Published: 2013

Journal Articles

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Colin Phipps, MD, Michael L. Linenberger, MD, Damian J. Green, MD, M. Corinna Palanca-Wessels, MD, PhD, Pamela S. Becker, MD, PhD, Laura S. Connelly-Smith, MBBCh, DM, Nicholas Burwick, MD, Zandra K. Klippel, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 4507.

https://doi.org/10.1182/blood.V122.21.4507.4507

Published: 2013

Journal Articles

Impaired ribosomal subunit association in Shwachman-Diamond syndrome

Nicholas Burwick, Scott A. Coats, Tomoka Nakamura, Akiko Shimamura

Blood (2012) 120 (26): 5143–5152.

https://doi.org/10.1182/blood-2012-04-420166

Published: 2012

Includes: Supplemental data

Journal Articles

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

Zandra K. Klippel, MD, Barry Storer, PhD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Pamela S Becker, MD, PhD, Damian J. Green, MD, Nicholas Burwick, MD, Edward N. Libby, III, MD

Blood (2012) 120 (21): 2016.

https://doi.org/10.1182/blood.V120.21.2016.2016

Published: 2012

Journal Articles

A 4-Drug, Weekly Combination Regimen of Bortezomib, Cyclophosphamide, Liposomal Doxorubicin, and Dexamethasone for Initial Treatment of Multiple Myeloma

Pamela S. Becker, MD, PhD, Ted A. Gooley, PhD, Kathy Lilleby, RN, Damian J. Green, MD, Nicholas Burwick, MD, Christine Wallace, Theodore Kim, DO, Kiarash Kojouri, MD, MPH, Erin Nelli, DO, William I. Bensinger, MD

Blood (2012) 120 (21): 5038.

https://doi.org/10.1182/blood.V120.21.5038.5038

Published: 2012

Journal Articles

SBDS and eIF6 Modulate Ribosome Subunit Joining in Shwachman Diamond Syndrome,

Nicholas Burwick, MD, Scott Coats, Akiko Shimamura, MD, PhD

Blood (2011) 118 (21): 3438.

https://doi.org/10.1182/blood.V118.21.3438.3438

Published: 2011

Journal Articles

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

Blood (2009) 113 (18): 4341–4351.

https://doi.org/10.1182/blood-2008-10-186668

Published: 2009

Includes: Supplemental data

Journal Articles

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia

Aldo M. Roccaro, Antonio Sacco, Changzhong Chen, Judith Runnels, Xavier Leleu, Feda Azab, Abdel Kareem Azab, Xiaoying Jia, Hai T. Ngo, Molly R. Melhem, Nicholas Burwick, Lyuba Varticovski, Carl D. Novina, Barrett J. Rollins, Kenneth C. Anderson, Irene M. Ghobrial

Blood (2009) 113 (18): 4391–4402.

https://doi.org/10.1182/blood-2008-09-178228

Published: 2009

Includes: Supplemental data

Journal Articles

MicroRNA Signature in Waldenstrom Macroglobulinemia

Aldo M Roccaro, Antonio Sacco, Changzhong Chen, Xavier Leleu, Judith Runnels, Feda Azab, Abdel Kareem Azab, Xiaoying Jia, Hai T Ngo, Molly R. Melhem, Nicholas Burwick, Phong Quang, Lyuba Varticovski, Carl D Novina, Barrett J. Rollins, Kenneth C. Anderson, Irene M. Ghobrial

Blood (2008) 112 (11): 630.

https://doi.org/10.1182/blood.V112.11.630.630

Published: 2008

Journal Articles

Proteomic Analysis of Multiple Myeloma Identifies Upregulation of CRIK Protein, a Novel Protein Regulating Migration and Adhesion

Hai T. Ngo, Evdoxia Hatjiharissi, MD, Alexey A. Leontovich, PhD, Wee Chng, PhD, Mena Farag, Xavier Leleu, MD, PhD, Xiaoying Jia, Judith Runnels, PhD, Aldo Roccaro, MD, PhD, Abdel Kareem Azab, PhD, Feda Azab, Antonio Sacco, Nicholas Burwick, MD, Molly R. Melhem, Kenneth C. Anderson, MD, Rafael Fonseca, MD, Thomas E. Witzig, MD, Irene M. Ghobrial, MD

Blood (2008) 112 (11): 643.

https://doi.org/10.1182/blood.V112.11.643.643

Published: 2008

Journal Articles

CXCR7 Regulates SDF-1 Induced Adhesion and Homing in Multiple Myeloma.

Nicholas Burwick, MD, Anne-Sophie Moreau, MD, Xiaoying Jia, Xavier Leleu, MD, PhD, Judith Runnels, Hai T. Ngo, Molly R. Melhem, Aldo M. Roccaro, MD, PhD, Abdel kareem Azab, PhD, Irene M. Ghobrial, M.D.

Blood (2008) 112 (11): 1674.

https://doi.org/10.1182/blood.V112.11.1674.1674

Published: 2008

Journal Articles

Rho-a and Rac-1 GTPases Play Major and Differential Roles in SDF1α- Induced Cell Adhesion and Chemotaxis in Multiple Myeloma.

Abdel kareem Azab, Feda Azab, Costas M Pitsillides, Hai T. Ngo, Xiaoying Jia, Molly R. Melhem, Judith Runnels, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Nicholas Burwick, Charles P Lin, Kenneth C Anderson, MD, Irene M. Ghobrial

Blood (2008) 112 (11): 1666.

https://doi.org/10.1182/blood.V112.11.1666.1666

Published: 2008

NARROW

Assessment of Minimal Residual Disease By Next-Generation Sequencing and Fluorodeoxyglucose-Positron Emission Tomography in Patients with Relapsed/Refractory Multiple Myeloma Treated with Venetoclax in Combination with Carfilzomib and Dexamethasone

Impact of Neurocognitive Dysfunction in a Veteran Population Undergoing First Outpatient Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Association of Monoclonal Gammopathy with Progression to End-Stage Renal Disease Among a National Cohort of US Veterans

Monoclonal Gammopathies: Electronic Subspecialty Consultation

Placental Growth Factor (PlGF) Enhances TLR/MK2 Dependent TNF Gene Transcription and Dissociates miRNAs Targeting TNF Regulatory Transcripts from the Polysome

Response: Maternal and cord C5a in response to eculizumab

CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma

Translational Profiling Reveals The eIF2 Kinase Pathway As a Mediator Of Dexamethasone Induced Apoptosis In Multiple Myeloma

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Impaired ribosomal subunit association in Shwachman-Diamond syndrome

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

A 4-Drug, Weekly Combination Regimen of Bortezomib, Cyclophosphamide, Liposomal Doxorubicin, and Dexamethasone for Initial Treatment of Multiple Myeloma

SBDS and eIF6 Modulate Ribosome Subunit Joining in Shwachman Diamond Syndrome,

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia

MicroRNA Signature in Waldenstrom Macroglobulinemia

Proteomic Analysis of Multiple Myeloma Identifies Upregulation of CRIK Protein, a Novel Protein Regulating Migration and Adhesion

CXCR7 Regulates SDF-1 Induced Adhesion and Homing in Multiple Myeloma.

Rho-a and Rac-1 GTPases Play Major and Differential Roles in SDF1α- Induced Cell Adhesion and Chemotaxis in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only